Trial · NCT00564850
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With a GnRH-stimulated LH Level ≤3 IU/L | 3 months after the first injection of triptorelin pamoate 11.25 mg | |
| Secondary | Number of Participants Whose Intravenous (i.v.) GnRH-stimulated LH Response Was ≤3 IU/L | Month 6 | |
| Secondary | Follicle Stimulating Hormone (FSH) Level Following GnRH Test | Screening, month 3 and 6 | |
| Secondary | Basal FSH Level | Month 0, 1, 2, 3, 4, 5, and 6 | |
| Secondary | Basal LH Level | Month 0, 1, 2, 3, 4, 5 and 6 | |
| Secondary | Number of Girls With Oestradiol Levels ≤ 20 pg/ml | Month 0, 1, 2, 3, 4, 5 and 6 | |
| Secondary | Testosterone Level | Month 0, 3 and 6 | |
| Secondary | Number of Girls With Inhibin B Levels < 6 pg/ml | Month 0, 3 and 6 | |
| Secondary | Change From Screening in Pubertal Stage (Tanner Method) at Month 6 | Between screening and month 6 | Pubertal stage (graded from 1 to 5 for penis and breast development, graded from 1 to 6 for pubic hair development) according to the Tanner method was collected. A low stage (i.e. 1) corresponds to a pre-pubertal stage and a high stage (i.e. 5 or 6) to an adult stage. Any increase of grade was defined as 'increased' and no change in grade or a reduced grade was defined as 'stabilised or reduced'. |
| Secondary | Height Standard Deviation Score (SDS) | Month 0, 3 and 6 | Standard deviation (SD) is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child. |
| Secondary | Body Mass Index (BMI) SDS | Month 0, 3 and 6 | |
| Secondary | Change From Baseline in Growth Velocity (GV) SDS at Month 6 | Baseline and month 6 | Change from baseline of GV was calculated as: GV at month 6 - GV at baseline. GV SDS was calculated using SAS algorithm. Growth velocity during the study was calculated using the two height measures as: GV = (Height at baseline - Height at screening)\*365/delay between two height measures. |
| Secondary | Difference Between Bone Age and Chronological Age | Month 0 and 6 | Bone age was defined according to Greulich and Pyle method. Chronological age was calculated using the date of birth. |
| Secondary | Uterine Length | Month 0, 3 and 6 | |
| Secondary | Triptorelin Plasma Levels | Month 1, 2, 3, 4, 5 and 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00564850/registered